Publications

5538 Results

Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.

Authors
G Falkson;RS Gelman;KJ Pandya;CK Osborne;D Tormey;FJ Cummings;GW Sledge;MD Abeloff
Journal / Conference
Journal of Clinical Oncology 16(5):1669-1676
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-8697 (INT-0077)

A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: A Southwest Oncology Group study (9031).

Authors
JE Godwin;KJ Kopecky;DR Head;CL Willman;CP Leith;HE Hynes;SP Balcerzak;FR Appelbaum
Journal / Conference
Blood 91(10):3607-3615
Year
1998
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031

BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: An Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study.

Authors
JN Winter;J Andersen;JC Reed;S Krajewski;D Variakojis;KD Bauer;RI Fisher;LI Gordon;MM Oken;S Jiang;D Jeffries;P Domer
Journal / Conference
Blood 91(4):1391-1398
Year
1998
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8516 (INT-0067)

Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents.

Authors
DE Banker;M Groudine;CL Willman;T Norwood;FR Appelbaum
Journal / Conference
Leukemia Research 22(3):221-239
Year
1998

Report on workshop regarding leukemia studies by SWOG cytogenetic laboratories.

Authors
G Kinzie
Journal / Conference
The Journal of the Association of Genetic Technologists 24(2):44-46
Year
1998
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9007

Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246.

Authors
OW Press;M LeBlanc;TJ O'Rourke;S Gagnet;RA Chapman;SP Balcerzak;RI Fisher
Journal / Conference
Journal of Clinical Oncology 16(2):574-578
Year
1998
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9246

Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials.

Authors
LE Flaherty;JM Unger;PY Liu;WC Mertens;VK Sondak
Journal / Conference
American Journal of Clinical Oncology 21(6):568-572
Year
1998
Research Committee(s)
Melanoma

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study.

Authors
AJ Wozniak;JJ Crowley;SP Balcerzak;GR Weiss;CH Spiridonidis;LH Baker;KS Albain;K Kelly;SA Taylor;DR Gandara;RB Livingston
Journal / Conference
Journal of Clinical Oncology 16(7):2459-2465
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-9308

Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: A Southwest Oncology Group study.

Authors
DJ Ahnen;P Feigl;G Quan;C Fenoglio-Preiser;LC Lovato;PA Bunn Jr;G Stemmermann;JD Wells;JS Macdonald;FL Meyskens Jr
Journal / Conference
Cancer Research 58:1149-1158
Year
1998
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9000

Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: A phase II study of the Southwest Oncology Group (SWOG-9229).

Authors
CR Thomas Jr;DJ Giroux;KJ Stelzer;JB Craig;LR Laufman;SA Taylor;JW Goodwin;JJ Crowley;RB Livingtson
Journal / Conference
Int J Radiat Oncol Biol Phys 40(5):1039-1047
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-9229